Skip to main content
National News Desk
health

Sellas’ cancer vaccine extends survival in blood cancer trial, company says

The Hindu Health & MedicalBy The Hindu Health & Medical
19 Nov 2026
Original: English
AI Synopsis & Key Briefing

The ⁠vaccine, called galinpepimut-S ⁠or GPS, was tested in patients with acute ​myeloid ‌leukaemia, a fast-growing cancer of the blood and bone marrow

Key Highlights & Official Takeaways
  • ✓The ⁠vaccine, called galinpepimut-S ⁠or GPS, was tested in patients with acute ​myeloid ‌leukaemia, a fast-growing cancer of the blood and bone marrow
  • ✓Patients ‌who received ​GPS lived a median of ⁠24 months, compared to 14.7 months ‌for those given the best available treatment, Sellas said.
  • ✓Civic Domain: Categorized under health public notices.
Comprehensive News & Policy Report

Sellas Life ‌Sciences said on Tuesday, November 17, 2026 that its ​experimental ⁠vaccine helped patients with a type of blood ‌cancer live longer in ‌a late-stage ‌trial. The ⁠vaccine, called galinpepimut-S ⁠or GPS, was tested in patients with acute ​myeloid ‌leukaemia, a fast-growing cancer of the blood and bone marrow.

Patients ‌who received ​GPS lived a median of ⁠24 months, compared to 14.7 months ‌for those given the best available treatment, Sellas said. The company plans to talk ‌to the U.S. Food ​and Drug Administration about seeking approval ⁠for the vaccine.

⁠Its shares were halted in premarket ‌trading.

Actionable Steps for Aspirants & Citizens
  • •Aspirants and citizens are advised to monitor official notices and circulars issued by The Hindu Health & Medical.
  • •Verify all prescribed eligibility criteria, cutoff dates, and authenticated document requirements prior to formal submissions.
  • •Track connected examination timetables, vacancy advisories, and administrative gazettes on SuchnaSetu.
Official Notice Specification
Issuing AuthorityThe Hindu Health & Medical
Topic CategoryHEALTH
JurisdictionAll India / National
Publication Date19 November 2026
Connected Government Jobs & Upcoming Exams
Active on SuchnaSetu
Official Source Attribution: The Hindu Health & Medical
View Publisher Source Link

SuchnaSetu provides verified civic and public policy reports based on official notices. Primary publication and copyright remain with the respective government authority or publisher.